✦ LIBER ✦

Outpatient chemotherapy for recurrent and/or advanced squamous cell carcinoma of the head and neck

✍ Scribed by N. Kohno; S. Kitahara; M. Kawaida; G. Ichikawa; T. Shirasaka

Publisher: Springer
Year: 1999
Tongue: English
Weight: 55 KB
Volume: 4
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s101470050069

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin and 5-fluorouracil chemotherap

Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck

✍ Richard J. Mercier; G. David Neal; Douglas E. Mattox; George A. Gates; Thomas C. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB 👁 3 views

Combination chemotherapy for advanced sq

Combination chemotherapy for advanced squamous cell carcinoma of the head and neck

✍ Coker, Donald D. ;Elias, E. George ;Chretien, Paul B. ;Gray, William C. ;Coleman 📂 Article 📅 1981 🏛 Wiley (John Wiley & Sons) ⚖ 639 KB

## Abstract Fifty‐one patients (32 previously untreated, 19 previously treated) with advanced squamous cell carcinoma of the head and neck received a single course of combination chemotherapy consisting of high dose __cis__‐platinum (DDP), bleomycin (Bleo), ± high dose methotrexate (MTX). Thirty‐th

Adjuvant chemotherapy for advanced head

Adjuvant chemotherapy for advanced head and neck squamous carcinoma

✍ Final report of the head; neck contracts program 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 1016 KB

To determine the efficacy of adjuvant chemotherapy in patients with advanced head and neck squamous carcinoma, the National Cancer Insitute initiated a multi-institutional, prospective randomized trial termed the Head and Neck Contracts Program. Between 1978 and 1982,462 patients with resectable Sta

Concomitant chemotherapy and radiotherap

Concomitant chemotherapy and radiotherapy for advanced squamous cell carcinoma of head and neck

✍ Seung Shin Hahn; Jung-Ah Kim; William C. Constable 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Reirradiation with Alternating Docetaxel

Reirradiation with Alternating Docetaxel-Based Chemotherapy for Recurrent Head and Neck Squamous Cell Carcinoma

✍ Bernhard Berger; Claus Belka; Martin Weinmann; Michael Bamberg; Wilfried Budach; 📂 Article 📅 2010 🏛 Springer 🌐 German ⚖ 116 KB

Paclitaxel, cisplatin, and 5-fluorouraci

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi